Income statement
USD
Annual
| Metric | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|
| Revenue | 31M | 1M | 442K | 0 |
| Gross Profit | 3M | -165K | -574K | -525 |
| Operating Income | -566K | -1M | -886K | -258K |
| EBITDA | -898K | -977K | -1M | -253K |
| Net Income | -4M | -2M | -1M | -101K |
| EPS (Diluted) | — | — | — | — |
Healthcare
Live Price
Offline$0.00001
+0.00% today
1Y Change
+0.00%
Window
Jun 20, 2025 → Jun 18, 2026
Coverage: 250 bars · Jun 20, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
YourWay Cannabis Brands Inc. (YOURF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 20, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +2920.8%, EPS growth of -12.1%, a dividend yield of 0.0%. What stands out right now is revenue +2920.8%, EPS -12.1%, free cash flow -62.8% with operating margin -1.9% and ROIC -5.5%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines YOURF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
YOURF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
YOURF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for YOURF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
-100.0% YoY
FY Net Income
-$101.2K
+92.8% YoY
Free Cash Flow
-$216.8K
+80.8% YoY
Revenue Growth
+2920.8%
EPS Growth
-12.1%
Gross Margin
10.2%
Net Margin
-11.7%
Income statement
USD
| Metric | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|
| Revenue | 31M | 1M | 442K | 0 |
| Gross Profit | 3M | -165K | -574K | -525 |
| Operating Income | -566K | -1M | -886K | -258K |
| EBITDA | -898K | -977K | -1M | -253K |
| Net Income | -4M | -2M | -1M | -101K |
| EPS (Diluted) | — | — | — | — |
Balance sheet
USD
| Metric | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|
| Cash & Equivalents | 1M | 1M | 47K | 79K |
| Total Assets | 15M | 6M | 569K | 868K |
| Total Liabilities | 10M | 5M | 545K | 569K |
| Shareholder Equity | 5M | 990K | 24K | 299K |
| Total Debt | 4M | 4M | 456K | 390K |
| Net Debt | 3M | 3M | 410K | 312K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
195K
+81.7% YoY
Capital Expenditures
22K
+67.3% YoY
Free Cash Flow
217K
+80.8% YoY
Key ratios
Gross Margin
10.2%
Operating Margin
-1.9%
Net Margin
-11.7%
ROE
-117.9%
Debt / Equity
0.86x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.